Effects of Nightshift Work and Sleep Disturbances on Erectile Function

Erectile Dysfunction, Nocturia, Short Term Insomnia, Obstructive Sleep Apnea Clinical Trial

Official title:

Effects of Nightshift Work and Sleep Disturbances on Erectile Function, Serum Testosterone Levels, Nocturia

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04707807
• Other study ID #: MedipolUrology
• Status: Recruiting
• Start date: November 20, 2020
• Est. completion date: November 20, 2021

Study information

• Verified date: January 2021
• Source: Istanbul Medipol University Hospital
• Contact: Gokhan Calik, Asst.Prof.
• Phone: +905362666604
• Email: gcalik[@]medipol.edu.tr
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

We aim to observe the unwanted effects of nightshift work and short term insomnia on erectile function of men aged between 25 to 60 years. We will also compare the levels of serum testosterone in the target group and compare it with the ones who don't work in hightshifts.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 300
• Est. completion date: November 20, 2021
• Est. primary completion date: May 20, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 25 Years to 60 Years

Eligibility

Inclusion Criteria:

• Suffering from erectile dysfunction

• Mainly psychogenic ED

• Employed

Exclusion Criteria:

• Patients with major organic causes erectile dysfunction (Radical pelvic surgery/radiation therapy, uncontrolled diabetis mellitus, uncontrolled hypertension, New York Heart Association Class 3-4 heart failure, acute coronary syndrome within 3 months, dyslipidemia)

• NEET(Not in employment, education, training) patients

Related Conditions & MeSH terms

• Dyssomnias
• Erectile Dysfunction
• Erectile Dysfunction, Nocturia, Short Term Insomnia, Obstructive Sleep Apnea
• Nocturia
• Parasomnias
• Sleep Apnea, Obstructive

Intervention

Diagnostic Test:
• IIEF-5
IIEF-15 form will be filled out by all participants

Locations

Country	Name	City	State
Turkey	Istanbul Medipol University Hospital	Bagcilar	Istanbul
Turkey	Cemil Tascioglu Cith Hospital	Istanbul	Sisli

Sponsors (2)

Lead Sponsor	Collaborator
Istanbul Medipol University Hospital	Prof. Dr. Cemil Tascioglu Education and Research Hospital Organization

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Erectile dysfunction	Decreased scores of IIEF-5	3-6 months